Form 8-K ZIMMER BIOMET HOLDINGS, For: May 04
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Zimmer Biomet (ZBH) PT Raised to $188 at Truist Securities Following Earnings
May 4, 2021 2:01 PM EDTTruist Securities analyst Kaila Krum raised the price target on Zimmer Biomet (NYSE: ZBH) to $188.00 (from $174.00) while maintaining a Buy rating.
The analyst commented, "Zimmer Biomet reported 1Q21 results with both revenue and adj. EPS above consensus. After focusing on the spinoff last quarter,... More
